Latest Breaking News On - Bristol myers squibb breyanzi - Page 1 : comparemela.com

A biotech reckoning: 'We've lost our luster in cell therapies'

A Special Report from the Fierce Biotech team on the state of cell therapy.

Boulder Care Raises $35 Million For Virtual Addiction Treatment

An FDA-approved AI algorithm is more likely to wrongly indicate breast cancer in Black women.

FDA approves Bristol Myers Squibb's Breyanzi for follicular lymphoma

The approval is based on results from the open-label, global, multicentre, single-arm Phase II TRANSCEND FL clinical trial.

FDA Grants Accelerated Approval to Liso-Cel for Relapsed/Refractory Follicular Lymphoma

T-Cell Exhaustion in CLL: Allogeneic CAR T Trial Reaching Patients With Unmet Need

"Off the shelf" CAR T-cell therapies could offer a solution in chronic lymphocytic leukemia, where T-cell exhaustion creates treatment challenges. This article will appear in the May 2024 issue of Evidence-Based Oncology.